维普中文期刊产品整合服务
20篇 您的检索式:作者名="Piers O"
    题名 作者 年代 出处 被引量
1Icreased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease显示文摘Maple-Brown LJ Piers LS O' Rourke MF 2007J Hypertens2007,25,3:1
2Increased arterial stiffness in remote indigenous Australians with High risk of cardiovascular disease显示文摘Maple-Brown LJ Piers LS O' Rourke MF 2007J Hypertens2007,25,3:1
3Detecting spatial-temporal precipitation variability in portugal using multichannel singular spectral analys 显示文摘Antunes S Piers O Rocha A 2006International Journal of Climatology2006,10,:1
4Rheumatoid arthritis sequences显示文摘PIER NS CARLO O 1998Eur J Radiol1998,27,:1
5Increased arterial stiffness inremote Indigenous Australians with high risk of cardiovascular disease显示文摘Maple-Brown L J Piers L S O' Rourke M F 2007Journal of Hypertension2007,25,3:1
6Increased arte rim stiffness in remote Indigenous Australians with high risk of cardiovascular disease显示文摘Maple-Brown LJ Piers LS O' Rourke MF 2007J Hypertens2007,25,:1
7Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease显示文摘Maple-Brown IJ Piers IS O' Rourke MF 0,,03:1
8Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status显示文摘 PIERS L S O'ROURKE M F 2005J Hypertens2005,23,7:1
9Increased arterial stiffness in remote indigenous australians with high risk of cardiovascular disease 显示文摘Maple-Brown L J Piers L S O' Rourke M F 2007J Hypertens2007,25,3:1
10Blue silver:A very sensitive colloidal Coomassie G-250 staining for proteome analysis显示文摘Giovanni C Maurizio Br Luca M Laura S Gian M G Barbara C Paola O Luciano Z and Pier G R 0,,09:1
11Blue silver:A very sensitive colloidal coomassie G-250 staining for proteome analysis显示文摘GIOVANNI C MAURRZIO B LUCA M LAURA S GIAN M G BARBARA C PAOLA O LUCIANO Z PIER G R 2004Electrophoresis2004,25,:1
12显示文摘Pier L G Fausto O Gianna F 2007Chemical Physics Letters2007,444,:1
13Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status显示文摘 Piers LS O'Rourke MF 2005J Hypertens2005,23,:1
14Increased arterial stiffness in remote indigenous australians with high risk of cardiovascular disease显示文摘Maple-Brown L J Piers L S O'Rourke M F 2007J Hypertens2007,25,3:1
15Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease 显示文摘Maple-Brown L J Piers L S O' Rourke M F 2007J Hypertens2007,25,3:1
16Increased arterial stiffness in remote Indigenous Australians with high risk cardiovascular disease显示文摘Maple-Brown LJ Piers KS O'Rourke MF 2007J Hypertens2007,25,3:1
17Sustainable biomass production:A comparison between Gross Energy Requirement and Emergy Synthesis methods显示文摘Pier Paolo Franzese T(o)rbjorn Rydberg Giovanni Fulvio Russo Sergio Ulgiati 2009Ecological indicators2009,,:1
18Total synthesis of ()-13- methoxy-15-oxozoapatlin, a rearranged kaurane diterpenoid 显示文摘Britton R A Piers E Patrick B O 2004J Org Chem2004,69,9:1
19Desimplification to multi-tablet antiretroviral regimens in human immunodeficiency virus-type 1 infected adults: A cohort study显示文摘BACKGROUND Highly active antiretroviral therapy (HAART) is provided free of charge to all human immunodeficiency virus (HIV) positive residents in Italy. As fixed dose coformulations (FDCs) are often more expensive in comparison to the same drugs administered separately in a multi-tablet regimen (MTR), we considered a costeffective strategy involving patients in the switch from their FDCs to corresponding MTRs including generic antiretrovirals. AIM To verify if this would affect the virological and immunological response in comparison to maintaining the FDC regimens. METHODS From January 2012 to December 2013, we assessed the eligibility of all the HIV-1 positive adults on stable HAART being treated at our hospital-based outpatient clinic in Treviso, Italy. Participants who accepted to switch from their FDC regimen to the corresponding MTR joined the MTR group, while those who maintained a FDC regimen joined the FDC group. Clinical data, including changes in HAART regimens, respective reasons why and adverse effects, were recorded at baseline and at follow-up visits occurring at weeks 24, 48 and 96. All participants were assessed for virological and immunological responses at baseline and at weeks 24, 48 and 96. RESULTS Two hundred and forty-three eligible HIV-1 adults on HAART were enrolled: 163 (67%) accepted to switch to a MTR, joining the MTR group, while 80 (33%) maintained their FDCs, joining the FDC group. In a parallel analysis, there were no significant differences in linear trend of distribution of HIV-RNA levels between the two groups and there were no significant odds in favour of a higher level of HIV-RNA in either group at any follow-up and on the overall three strata analysis. In a before-after analysis, both FDC and MTR groups presented no significant differences in distribution of HIV-RNA levels at either weeks 48 vs 24 and weeks 96 vs 24 cross tabulations. A steady increase of mean CD4 count was observed in the MTR group only, while in the FDC group we observed a slight decrease (-23 cells per mmc) between weeks 24 and 48. CONCLUSION Involving patients in the switch from their FDC regimens to the corresponding MTRs for economic reasons did not affect the effectiveness of antiretroviral therapy in terms of virological response and immunological recovery.Maria C Rossi Walter O Inojosa Giuseppe Battistella Antonella Carniato Francesca Farina Mario Giobbia Rodolfo Fuser Pier G Scotton 2019World Journal of Clinical Cases2019,7,14:0
20Mycobacterium chimaera infections following cardiac surgery in Treviso Hospital, Italy, from 2016 to 2019: Cases report显示文摘BACKGROUND An epidemic of Mycobacterium chimaera (M. chimaera) infections following cardiac surgery is ongoing worldwide. The outbreak was first discovered in 2011, and it has been traced to a point source contamination of the LivaNova 3T heater-cooler unit, which is used also in Italy. International data are advocated to clarify the spectrum of clinical features of the disease as well as treatment options and outcome. We report a series of M. chimaera infections diagnosed in Treviso Hospital, including the first cases notified in Italy in 2016. CASE SUMMARY Since June 2016, we diagnosed a M. chimaera infection in nine patient who had undergone cardiac valve surgery between February 2011 and November 2016. The time between cardiac surgery and developing symptoms ranged from 6 to 97 mo. Unexplained fever, psychophysical decay, weight loss, and neurological symptoms were common complaints. The median duration of symptoms was 32 wk, and the longest was almost two years. A new cardiac murmur, splenomegaly, choroidoretinitis, anaemia or lymphopenia, abnormal liver function tests and hyponatremia were common findings. All the patients presented a prosthetic valve endocarditis, frequently associated to an ascending aortic pseudoneurysm or spondylodiscitis. M. chimaera was cultured from blood, bioprosthetic tissue, pericardial abscess, vertebral tissue, and bone marrow. Mortality is high in our series, reflecting the poor outcome observed in other reports. Three patients have undergone repeat cardiac surgery. Five patients are being treated with a targeted multidrug antimycobacterial regimen. CONCLUSION Patients who have undergone cardiac surgery in Italy and presenting with signs and symptoms of endocarditis must be tested for M. chimaera.Walter O Inojosa Mario Giobbia Giovanna Muffato Giuseppe Minniti Francesco Baldasso Antonella Carniato Francesca Farina Gabriella Forner Maria C Rossi Stefano Formentini Roberto Rigoli Pier G Scotton 2019World Journal of Clinical Cases2019,7,18:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费